SCHEMBL25636629

SCHEMBL25636629

Cn1c(-c2cc3ccccc3c3c2oc2ccccc23)nc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.59
KDM4E B2RXH2 10/20 0.59
RAB9A P51151 9/20 0.59
ALDH1A1 P00352 10/20 0.47
SMN1; SMN2 Q16637 8/20 0.47
HPGD P15428 7/20 0.47
MAPT P10636 6/20 0.47
GAA P10253 6/20 0.47
TP53 P04637 4/20 0.47
PKM P14618 4/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
TSHR P16473 3/20 0.44
HSD17B10 Q99714 3/20 0.44
CASP1 P29466 2/20 0.44
CASP7 P55210 2/20 0.44
ATM Q13315 2/20 0.44
HCRTR1 O43613 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26012093 0.80 KDM4E (0.47) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL23106482 0.80 KDM4E (0.54) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL15394368 0.79 ALDH1A1 (0.48) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL25634480 0.78 KDM4E (0.50) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL9976897 0.77 KDM4E (0.53) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL16692191 0.75 KDM4E (0.64) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL15393862 0.75 ALDH1A1 (0.51) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL4386113 0.74 NPC1 (1.00) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
SCHEMBL29635856 0.74 NPC1 (1.00) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2
Neocryptolepine SCHEMBL1833360 0.74 TERT (0.59) NPC1KDM4ERAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11683981-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11683981-B2 Organic electroluminescent materials and devices OXER1, CHRM1, OSBPL8 NPC1 1667/4885KDM4E 3627/4885RAB9A 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.